Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (496)
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,869
Price
$357.67
Total Value
$5.68M
Shares Held After
195,777
% of Holdings
7.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
12,418
Price
$356.62
Total Value
$4.43M
Shares Held After
211,646
% of Holdings
5.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,476
Price
$355.66
Total Value
$1.24M
Shares Held After
224,064
% of Holdings
1.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,717
Price
$354.78
Total Value
$2.38M
Shares Held After
227,540
% of Holdings
2.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,673
Price
$353.32
Total Value
$1.30M
Shares Held After
234,257
% of Holdings
1.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,813
Price
$351.80
Total Value
$989.60K
Shares Held After
237,930
% of Holdings
1.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
67
Price
$350.00
Total Value
$23.45K
Shares Held After
240,743
% of Holdings
0.0%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
10,125
Price
$26.07
Total Value
$263.96K
Shares Held After
62,291
% of Holdings
14.0%
Replimune Group, Inc. (REPL)
Patel Sushil — Director
Shares
39,341
Price
$12.97
Total Value
$510.25K
Shares Held After
708,151
% of Holdings
5.3%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$20.00
Total Value
$13.58K
Shares Held After
51,776
% of Holdings
1.3%
Replimune Group, Inc. (REPL)
Xynos Konstantinos — Chief Medical Officer
Shares
11,447
Price
$12.97
Total Value
$148.47K
Shares Held After
224,215
% of Holdings
4.9%
Replimune Group, Inc. (REPL)
Schwendenman Andrew — Chief Accounting Officer
Shares
7,632
Price
$12.97
Total Value
$98.99K
Shares Held After
99,425
% of Holdings
7.1%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
239,850
Price
$133.27
Total Value
$31.96M
Shares Held After
98,744
% of Holdings
70.8%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
11,448
Price
$12.97
Total Value
$148.48K
Shares Held After
225,108
% of Holdings
4.8%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
12,500
Price
$27.97
Total Value
$349.59K
Shares Held After
129,855
% of Holdings
8.8%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
800
Price
$800.00
Total Value
$640.00K
Shares Held After
1,703
% of Holdings
32.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
10,000
Price
$27.98
Total Value
$279.75K
Shares Held After
362,152
% of Holdings
2.7%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
18,750
Price
$27.98
Total Value
$524.53K
Shares Held After
181,641
% of Holdings
9.4%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Watton Corey Michael — Director
Shares
12,300
Price
$11.25
Total Value
$138.38K
Shares Held After
1,800
% of Holdings
87.2%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
4,770
Price
$114.04
Total Value
$543.96K
Shares Held After
3,985
% of Holdings
54.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
11,530
Price
$113.18
Total Value
$1.30M
Shares Held After
8,755
% of Holdings
56.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
1,031
Price
$114.52
Total Value
$118.07K
Shares Held After
9,755
% of Holdings
9.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
Guarini Kathryn — Director
Shares
400
Price
$800.00
Total Value
$320.00K
Shares Held After
603
% of Holdings
39.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
8,370
Price
$46.75
Total Value
$391.28K
Shares Held After
515,066
% of Holdings
1.6%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
14,171
Price
$45.97
Total Value
$651.49K
Shares Held After
523,436
% of Holdings
2.6%
NextCure, Inc. (NXTC)
Simcere Zaiming, Inc. — Former 10% Owner
Shares
30,000
Price
$6.16
Total Value
$184.80K
Shares Held After
308,636
% of Holdings
8.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,300
Price
$100.14
Total Value
$230.32K
Shares Held After
194,309
% of Holdings
1.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,017
Price
$99.25
Total Value
$597.19K
Shares Held After
196,609
% of Holdings
3.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
11,683
Price
$98.51
Total Value
$1.15M
Shares Held After
202,626
% of Holdings
5.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,626
Price
$102.80
Total Value
$167.15K
Shares Held After
40,418
% of Holdings
3.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
397
Price
$111.77
Total Value
$44.37K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
470
Price
$111.05
Total Value
$52.19K
Shares Held After
397
% of Holdings
54.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
272
Price
$109.96
Total Value
$29.91K
Shares Held After
867
% of Holdings
23.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
831
Price
$108.95
Total Value
$90.54K
Shares Held After
1,139
% of Holdings
42.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
737
Price
$108.17
Total Value
$79.72K
Shares Held After
1,970
% of Holdings
27.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
70
Price
$107.11
Total Value
$7.50K
Shares Held After
2,707
% of Holdings
2.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
700
Price
$111.41
Total Value
$77.99K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,000
Price
$110.64
Total Value
$110.64K
Shares Held After
700
% of Holdings
58.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,800
Price
$109.30
Total Value
$196.74K
Shares Held After
1,700
% of Holdings
51.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
2,800
Price
$108.38
Total Value
$303.46K
Shares Held After
3,500
% of Holdings
44.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,450
Price
$107.58
Total Value
$155.99K
Shares Held After
6,300
% of Holdings
18.7%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
16,167
Price
$110.38
Total Value
$1.78M
Shares Held After
0
% of Holdings
100.0%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
390
Price
$14.34
Total Value
$5.59K
Shares Held After
73,488
% of Holdings
0.5%
Lyell Immunopharma, Inc. (LYEL)
Bulis Veronica Sanchez — VP, Corporate Controller
Shares
621
Price
$14.34
Total Value
$8.91K
Shares Held After
14,799
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
214
Price
$538.86
Total Value
$115.32K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
186
Price
$537.91
Total Value
$100.05K
Shares Held After
324,657
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
514
Price
$536.23
Total Value
$275.62K
Shares Held After
324,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
286
Price
$535.27
Total Value
$153.09K
Shares Held After
325,357
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$533.21
Total Value
$208.49K
Shares Held After
325,643
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$532.28
Total Value
$244.32K
Shares Held After
326,034
% of Holdings
0.1%
Showing 51–100 of 496 transactions (page 2 of 10)